Literature DB >> 12407693

Molecular cytogenetic aspects of hematological malignancies: clinical implications.

Zhong Chen1, Avery A Sandberg.   

Abstract

The field of molecular cytogenetics has had a great impact on many aspects of medical and basic sciences. During the past 30 years, the application of molecular cytogenetic methodologies has resulted in remarkable advances in the field of cancer genetics and cytogenetics. These advances have led to the establishment of chromosome patterns as diagnostic and prognostic indexes in an array of acute and chronic leukemias and lymphomas, as key information in BMT, and as guides for the localization of oncogenes and tumor suppressor genes that are apparently responsible for the development of neoplastic states. With such information, the physician is in a more favorable position to devise therapy, appraise diagnosis, and plan follow-up. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2002        PMID: 12407693     DOI: 10.1002/ajmg.10689

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  6 in total

1.  Acute myeloid leukemia (AML-M2) with translocation (8;21) (q22;q22) and abnormal eosinophilic precursors in the bone marrow--a case report.

Authors:  Oneal Gupta; Roopak Aggarwal; Rajni Prasad
Journal:  Indian J Pediatr       Date:  2011-06-01       Impact factor: 1.967

2.  Fluorescence in situ hybridization analysis of immunoglobulin heavy chain translocations in plasma cell myeloma using intact paraffin sections and simultaneous CD138 immunofluorescence.

Authors:  James R Cook; Marybeth Hartke; James Pettay; Raymond R Tubbs
Journal:  J Mol Diagn       Date:  2006-09       Impact factor: 5.568

3.  Confirmation of the reported association of clonal chromosomal mosaicism with an increased risk of incident hematologic cancer.

Authors:  Ursula M Schick; Andrew McDavid; Paul K Crane; Noah Weston; Kelly Ehrlich; Katherine M Newton; Robert Wallace; Ebony Bookman; Tabitha Harrison; Aaron Aragaki; David R Crosslin; Sophia S Wang; Alex P Reiner; Rebecca D Jackson; Ulrike Peters; Eric B Larson; Gail P Jarvik; Christopher S Carlson
Journal:  PLoS One       Date:  2013-03-22       Impact factor: 3.240

4.  A de novo acute myeloid leukemia (AML-M4) case with a complex karyotype and yet unreported breakpoints.

Authors:  Walid Al-Achkar; Abdulmunim Aljapawe; Moneeb Abdullah Kassem Othman; Abdulsamad Wafa
Journal:  Mol Cytogenet       Date:  2013-05-05       Impact factor: 2.009

5.  De novo acute myeloid leukemia subtype-M4 with initial trisomy 8 and later acquired t(3;12)(q26;p12) leading to ETV6/MDS1/EVI1 fusion transcript expression: A case report.

Authors:  Walid Al Achkar; Abdulmunim Aljapawe; Thomas Liehr; Abdulsamad Wafa
Journal:  Oncol Lett       Date:  2014-01-08       Impact factor: 2.967

6.  New translocation in acute myeloid leukemia M4 eos.

Authors:  Gholamreza Bahoush; Maryam Vafapour; Roxana Kariminejad
Journal:  Leuk Res Rep       Date:  2020-06-08
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.